Meet our team
Management with a proven track record
|
Prior to founding Montara, Drs. Hertz and Shokat founded Mitokinin, acquired by AbbVie in 2023 |
|
|
The Shokat lab was first to invent small molecules to target K-Ras G12C, culminating in the FDA approval of sotorasib (Lumakras) in 2021 |
|
|
Publications from the founding team include Nature, Cell, Science, Proceedings of the National Academy of Sciences, Nature Neuroscience, Journal of Biological Chemistry, and Neuron |
Scientific advisory board with deep capabilities in neurodegeneration
|
Includes members of the National Academy of Sciences and Medicine, a Sjöberg Laureate, a Nobel Laureate, and an NIH New Innovator and Rainwater Prize recipient |
|
|
Expertise in protein aggregation, synaptic transmission, synapse formation, and their importance in Alzheimer’s disease and neurodegeneration |
|
|
Pioneering work in functional genomic CRISPR screens in the relevant cell types for neurodegeneration, including neurons, astrocytes, and microglia |
Management
Scientific Advisory Board
Kevan Shokat, PhD
Co-Scientific Founder & Chairman of the SAB
Thomas Südhof, MD
Co-Scientific Founder & SAB Member
Chemistry and Development Advisors
Board of Directors
Investors
And others
